
Saudi Arabia q-PCR Reagents Market - Industry Trends and Forecast to 2030
Description
Saudi Arabia q-PCR Reagents Market - Industry Trends and Forecast to 2030
The Saudi Arabia q-PCR Reagents Market is expected to reach USD 41,798.44 thousand by 2030, from USD 22,521.24 thousand in 2022 growing at the CAGR of 8.3 % in the forecast period of 2023 to 2030.
Market Segmentation
Saudi Arabia q-PCR Reagents Market, By Type (Reagents and Consumables), Application (Clinical, Research, Food Product Safety Testing, Forensics, and Others), End User (Hospitals, Diagnostic Centers, Pharmaceutical and Biopharmaceutical Companies, Research and Academic Institute, Clinical Research Organization, Veterinary Labs, Forensic Laboratories, and Others), Distribution Channel (Direct Tenders, Retail Sales, and Others) - Industry Trends and Forecast to 2030
Overview of Saudi Arabia q-PCR Reagents Market Dynamics
Driver
• Increasing prevalence of chronic and communicable diseases
Restraint
• Stringent rules and regulations
Opportunity
• Rise in government funding for healthcare
Market Players
Some of the key players operating in the Saudi Arabia q-PCR reagents market are:
• F. Hoffmann-La Roche Ltd
• Thermo Fisher Scientific Inc.
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Quantabio
• Sino Biological Inc.
• QIAGEN
• TAKARA HOLDINGS INC
• Enzo Biochem Inc.
• meridian BIOSCIENCE
• Tonbo Biosciences (A subsidiary of Cytek Biosciences)
• Norgen Biotek Corp.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Table of Contents
100 Pages
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of Saudi Arabia Q-pcr Reagents Market
- 1.4 Limitations
- 1.5 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Products Lifeline Curve
- 2.8 Primary Interviews With Key Opinion Leaders
- 2.9 Dbmr Market Position Grid
- 2.10 Market End User Coverage Grid
- 2.11 Secondary Sources
- 2.12 Assumptions
- 3 Executive Summary
- 4 Premium Insight
- 4.1 Pestel Analysis
- 4.2 Porter’s Five Forces
- 4.3 Global Qpcr Reagents Market, Pricing Analysis
- 5 Cost Analysis Breakdown
- 6 Healthcare Economy
- 7 Industry Insights
- 8 Innovation Tracker And Strategic Analysis
- 9 Technology Roadmap
- 10 Value Chain Analysis
- 11 Regulations
- 12 Market Overview
- 12.1 Drivers
- 12.1.1 Increasing Prevalence Of Chronic And Communicable Diseases
- 12.1.2 Increase In Geriatric Population
- 12.1.3 Increase In Early Diagnosis Rate
- 12.1.4 Increase In Advanced Technology
- 12.2 Restraints
- 12.2.1 Stringent Rules And Regulations
- 12.2.2 High Cost Of Product
- 12.3 Opportunities
- 12.3.1 Rise In Government Funding For Healthcare
- 12.3.2 Rise In Healthcare Expenditure
- 12.4 Challenges
- 12.4.1 Lack Of Skilled Workforce
- 12.4.2 Operational Barriers Faced In Conducting Diagnostic Tests
- 13 Saudi Arabia Qpcr Reagents Market, By Type
- 13.1 Overview
- 13.2 Reagents
- 13.2.1 Master Mix
- 13.2.1.1 Dna
- 13.2.1.2 Rna
- 13.2.2 Primers And Dntps
- 13.2.3 Assay
- 13.2.4 Nucleic Acid Gel Stain
- 13.2.5 Dnase Buffer
- 13.2.6 Others
- 13.2. Consumables
- 13.2.1. Pipette Tips
- 13.2.2. Tubes
- 13.2.3. Plates
- 13.2.3.1. Standard
- 13.2.3.2. Custom
- 13.2.4. Sealing Foils
- 13.2.5. Tube Strips
- 13.2.6. Others 56
- 14. Saudi Arabia Qpcr Reagents Market, By Application
- 14.2. Overview
- 14.3. Clinical
- 13.3 Human Diagnostics
- 14.3.1.1. Hospitals
- 14.3.1.2. Diagnostic Centers
- 14.3.1.3. Pathology Labs
- 14.3.1.4. Others
- 13.4 Veterinary Diagnostics
- 14.3.1.5. Veterinary Hospitals
- 14.3.1.6. Diagnostic Centers
- 14.3.1.7. Veterinary Laboratory
- 14.3.1.8. Veterinary Clinics
- 14.4. Research
- 14.4.1. Gene Expression Analysis
- 14.4.1.1. Research & Academic Institutes
- 14.4.1.2. Pharmaceutical & Biotechnology Companies
- 14.4.1.3. Others
- 14.4.2. Genotyping
- 14.4.2.1. Research & Academic Institutes
- 14.4.2.2. Pharmaceutical & Biotechnology Companies
- 14.4.2.3. Others
- 14.4.3. Microbe And Pathogen Detection
- 14.4.3.1. Research & Academic Institutes
- 14.4.3.2. Pharmaceutical & Biotechnology Companies
- 14.4.3.3. Others
- 14.4.4. Single Nucleotide Polymorphism (Snp) Detection
- 14.4.4.1. Research & Academic Institutes
- 14.4.4.2. Pharmaceutical & Biotechnology Companies
- 14.4.4.3. Others
- 14.4.5. Drug Development
- 14.4.5.1. Pharmaceutical & Biotechnology Companies
- 14.4.5.2. Clinical Research Organization
- 14.4.5.3. Research & Academic Institutes
- 14.4.5.4. Others 66
- 14.4.6. Drug Discovery
- 14.4.6.1. Pharmaceutical & Biotechnology Companies
- 14.4.6.2. Clinical Research Organization
- 14.4.6.3. Research & Academic Institutes
- 14.4.6.4. Others
- 14.4.7. Others
- 14.5. Food Product Safety Testing
- 14.5.1. Food Regulatory Agencies
- 14.5.2. Food Testing Laboratories
- 14.5.3. Food Companies
- 14.5.4. Others
- 14.6. Forensics
- 14.6.1. Private Forensic Laboratories
- 14.6.2. Public Forensic Laboratories
- 14.7. Others
- 15. Saudi Arabia Qpcr Reagents Market, By End User
- 15.2. Overview
- 15.3. Hospitals
- 15.4. Diagnostic Centers
- 15.5. Pharmaceutical And Biopharmaceutical Companies
- 15.6. Research & Academic Institute
- 15.7. Clinical Research Organization
- 15.8. Veterinary Labs
- 15.9. Forensic Laboratories
- 15.10. Others
- 16. Saudi Arabia Qpcr Reagents Market, By Distribution Channel
- 16.2. Overview
- 16.3. Direct Tender
- 16.4. Retail Sales
- 16.5. Others
- 17. Saudi Arabia Qpcr Reagents Market: Company Landscape
- 17.2. Company Share Analysis: Saudi Arabia
- 18. Swot Analysis 78
- 19. Company Profile
- 19.2. F. Hoffmann-la Roche Ltd
- 19.2.1. Company Snapshot
- 19.2.2. Revenue Analysis
- 19.2.3. Product Portfolio
- 19.2.4. Recent Development
- 19.3. Thermo Fisher Scientific Inc.
- 19.3.1. Company Snapshot
- 19.3.2. Revenue Analysis
- 19.3.3. Product Portfolio
- 19.3.4. Recent Developments
- 19.4. Agilent Technologies, Inc.
- 19.4.1. Company Snapshot
- 19.4.2. Revenue Analysis
- 19.4.3. Product Portfolio
- 19.4.4. Recent Developments
- 19.4.4.1. Distribution Agreement
- 19.4.4.2. Product Launch
- 19.5. Bio-rad Laboratories, Inc.
- 19.5.1. Company Snapshot
- 19.5.2. Revenue Analysis
- 19.5.3. Product Portfolio
- 19.5.4. Recent Developments
- 19.6. Quantabio
- 19.6.1. Company Snapshot
- 19.6.2. Product Portfolio
- 19.6.3. Recent Development
- 19.7. Enzo Biochem Inc
- 19.7.1. Company Snapshot
- 19.7.2. Revenue Analysis
- 19.7.3. Product Portfolio
- 19.7.4. Recent Development
- 19.8. Meridian Bioscience
- 19.8.1. Company Snapshot
- 19.8.2. Product Portfolio
- 19.8.3. Recent Developments 90
- 19.9. Norgen Biotek Corp
- 19.9.1. Company Snapshot
- 19.9.2. Product Portfolio
- 19.9.3. Recent Development